Profil
Marc Buyse is the founder of One2treat SA, founded in 2023.
Dr. Buyse is the founder of International Drug Development Institute SA, founded in 1988, holding the title of Chairman & Chief Scientific Officer.
Dr. Buyse was the founder of CluePoints SA, founded in 2012, having held the title of Chief Scientific Officer.
Dr. Buyse is currently the Managing Director & Director at Clinimetrics SA since 2007.
Aktive Positionen von Marc Buyse
| Unternehmen | Position | Beginn |
|---|---|---|
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services Provides biostatistics and e-Clinical solutions for phase I-IV clinical trials | Gründer | 01.01.1991 |
Clinimetrics SA
Clinimetrics SA Miscellaneous Commercial ServicesCommercial Services Provides market research services | Vorstandsvorsitzender | 23.06.2007 |
Ehemalige bekannte Positionen von Marc Buyse
| Unternehmen | Position | Ende |
|---|---|---|
CluePoints SA
CluePoints SA Packaged SoftwareTechnology Services Develops AI-powered and machine learning software solutions to clinical research | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services Provides biostatistics and e-Clinical solutions for phase I-IV clinical trials | Commercial Services |
CluePoints SA
CluePoints SA Packaged SoftwareTechnology Services Develops AI-powered and machine learning software solutions to clinical research | Technology Services |
Clinimetrics SA
Clinimetrics SA Miscellaneous Commercial ServicesCommercial Services Provides market research services | Commercial Services |
















